R5 Macrophage-Tropic HIV-1 in the Male Genital Tract by Bednar, Maria M. et al.
R5 Macrophage-Tropic HIV-1 in the Male Genital Tract
Maria M. Bednar,a Blake M. Hauser,a Li-Hua Ping,a Elena Dukhovlinova,a Shuntai Zhou,a Kathryn T. Arrildt,b Irving F. Hoffman,c
Joseph J. Eron,c Myron S. Cohen,c Ronald Swanstroma,b,d
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USAa; Department of Microbiology and Immunology,
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USAb; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina, USAc; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USAd
The entry tropism of HIV-1 Env proteins from virus isolated from the blood and genital tract of five men with compartmental-
ized lineages was determined. The Env proteins isolated from the genital tract of subject C018 were macrophage-tropic proteins,
while the remaining cloned env genes encoded R5 T cell-tropic proteins. The detection of a macrophage-tropic lineage of HIV-1
within the male genital tract strongly suggests that evolution of macrophage-tropic viruses can occur in anatomically isolated
sites outside the central nervous system.
Human immunodeficiency virus type 1 (HIV-1) developsconsiderable genetic diversity within an infected person.
Typically, this diversity has been analyzed as that of the viral
population in the blood; however, virus can also be detected in
other bodily fluids (reviewed in reference 1). Most virus de-
tected in the blood is likely produced in lymphoid tissues that
are not themselves easily sampled; thus, our knowledge of
HIV-1 diversity across tissues is limited (2). Furthermore, this
limitation affects our ability to analyze the possible unequal
distributions of viral diversity throughout the infected host,
which could affect treatment and cure efforts. Virus in the
blood typically requires high levels of CD4 and uses the CCR5
coreceptor (R5 T cell-tropic), with virus that can use the
CXCR4 receptor evolving later in disease (X4 T cell-tropic)
(3–5). Evolution resulting in the ability to use low levels of CD4
is associated with the ability to enter macrophages, and viruses
with this phenotype (CD4low/macrophage-tropic) are typically
found late in disease in some subjects and within the central
nervous system (CNS) (6). In this current study, we investi-
gated viral tropism in 5 previously identified subjects with
compartmentalized HIV-1 lineages in semen relative to blood
(7). We show in one subject a clear example of a macrophage-
tropic lineage of HIV-1 within the male genital tract. This ob-
servation demonstrates that macrophage-tropic viruses can oc-
cur in anatomical sites outside the CNS.
HIV-1 was analyzed from subjects who were recruited and
who consented to participation and enrolled for a previous
study (7, 8). CD4 T cell levels, viral loads, and GenBank ac-
cession numbers for the analyzed envelope genes are presented
in Table 1. Previous analysis of viral RNA sequences in the
seminal and blood plasma samples, performed first using a
V3-specific heteroduplex tracking assay and then, more re-
cently, using endpoint dilution PCR (i.e., single-genome am-
plification [SGA]) and sequence analysis, showed that a group
of the seminal plasma-derived viral sequences from each of
these five subjects formed a lineage genetically distinct from
those of virus in the blood of the same subject (7, 9). Now we
have performed phenotypic analysis of a subset of the full-
length env genes amplified from each subject to determine the
entry phenotype with respect to the ability to enter cells effi-
ciently using low levels of CD4.
Representative env gene amplicons from the major viral
population lineages in the blood and semen of all 5 subjects
were selected for cloning and phenotypic analysis as pseu-
dotyped virus. Briefly, the env gene was cloned into an expres-
sion vector, and each clone was cotransfected with the pNL4-
3.LucR-E reporter backbone plasmid into 293T cells to
generate an Env-pseudotyped luciferase reporter virus as de-
scribed previously (6, 9, 10). Viral tropism was evaluated based
on the ability to infect Affinofile cells expressing either high or
low levels of CD4. Comparing infection levels of Affinofile cells
expressing high versus low levels of surface CD4 provides a
consistent assessment of the evolutionary step required to effi-
ciently infect macrophages, i.e., the ability to infect cells with a
low density of CD4 (6). When the level of residual infectivity of
CD4low cells was 10% that of CD4high cells or greater, this was
scored as a CD4low/macrophage-tropic entry phenotype. Relative
infectivity of CD4low cells of 2% or less indicated that the virus was
T cell-tropic, and relative infectivity between those bounds con-
stituted intermediate tropism. Viruses evolving the ability to in-
fect cells with a low density of CD4 also become sensitive to
neutralization by soluble CD4 (sCD4) early in the process (11–
14). Thus, sensitivity to neutralization by sCD4 can be used to
confirm macrophage tropism (15) by testing the sensitivity of
infection to the presence of 5.0 g/ml sCD4 when infecting
TZM-bl cells. This amount of sCD4 efficiently inhibits the sen-
sitive M-tropic viruses, while R5 T cell-tropic viruses are rela-
tively resistant to this concentration.
The entry phenotype of the semen-compartmentalized viral
population in all five subjects was initially established by as-
sessing the tropism of one to three Env proteins from both the
blood and seminal plasma samples (Fig. 1). This initial analysis
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showed C018 to be the only subject with macrophage-tropic
virus, which was found only in the semen. To confirm this
finding, we reexamined multiple additional sequences from
this subject, creating a more extensive sampling of viral pro-
teins for entry phenotype analysis (Fig. 2). Clones were gener-
ated for 12 viral env gene amplicons from the seminal plasma
and for 4 env gene amplicons from the subject’s blood plasma.
By this measure, clones from five env genes from the seminal
plasma compartmentalized lineage-encoded Env proteins that
were macrophage-tropic, with relative infectivity values rang-
ing from 18% to 25% (Fig. 3A). One amplicon from the semi-
nal plasma encoded a protein that displayed an intermediate
tropism phenotype, with relative infectivity of 8%. The re-
maining env clones, six from seminal plasma and four from
blood plasma (all grouping together in Fig. 2) encoded proteins
that were T cell-tropic with a relative infectivity of less than 2%
on CD4low cells (Fig. 3A). All of the pseudotyped viruses tested
used CCR5 and not CXCR4 as a coreceptor for entry (data not
shown).
Pseudotyped viruses from C018 were also evaluated for sensi-
tivity to sCD4 (Fig. 3B). The presence of a low concentration of
sCD4 significantly inhibited the infectivity of the pseudotyped
viruses generated from the five macrophage-tropic viruses dis-
cussed above. In contrast, the 10 R5 T cell-tropic virus strains (6
from seminal plasma and 4 from blood plasma) were relatively
resistant to sCD4 at the concentration tested. The clone with the
intermediate entry phenotype showed intermediate sensitivity to
sCD4 and represented a distinct lineage within the seminal plasma
(Fig. 2).
HIV-1 from subject C018 constitutes the first clear demon-
stration of a population of macrophage-tropic virus outside the
CNS in humans using the strict criteria of (i) env genes gener-
ated by endpoint dilution PCR, (ii) a genetically compartmen-
talized population, (iii) an entry phenotype determined using a
well-controlled experimental approach where CD4 utilization
can be assessed, and (iv) an entry phenotype confirmed by
increased sensitivity to sCD4. The male genital tract has been
shown to undergo depletion of CD4 T cells during chronic
HIV-1 infection, and macrophages have been suggested to be
an alternative host cell (7, 16), which could explain the emer-
gence of a macrophage-tropic viral population in this subject,
who had low levels of CD4 T cells in the blood at the time of
sampling (116/l; Table 1). Macrophage-tropic viruses, as de-
termined by a capacity to infect human macrophages, have
previously been identified in human lymphoid tissue from pa-
tients with HIV-associated dementia, but macrophage entry
did not correlate with sCD4 sensitivity (17, 18). Significant
infection of macrophages in peripheral tissues of macaques has
FIG 1 Tissue culture assays using pseudoviruses to define viral entry tro-
pism phenotypes. Relative levels of infectivity of pseudoviruses (repre-
sented by blue bars for seminal Env and red bars for plasma Env) were
determined by using Affinofile cells expressing low levels of CD4 compared
to the level of pseudovirus infection of Affinofile cells induced to express
high levels of CD4. Macrophage tropism is defined by relative infectivity of
greater than 10%, while T cell tropism is defined by relative infectivity of
less than 2%. Relative infectivity from 2% to 10% constitutes intermedi-
ate tropism. Results show that only 1 Env from the semen of C018 showed
macrophage tropism and that C047 and C083 had 1 intermediate-tropism
Env from the semen whereas all other Env showed T cell-tropic phenotypes
from both the blood and semen. BAL, BaL viral Env protein; JRCSF, viral
Env protein; AID, amplicon identifier; PID, patient identifier.
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a PID, patient identifier; VL, viral load; Amplicon ID, amplicon identifier.
b Data represent log10 of the HIV-1 RNA load.
c Data represent numbers of CD4 T lymphocytes per cubic millimeter.
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been described during late-stage infection with a highly patho-
genic X4 simian-human immunodeficiency virus (SHIV) and
early in infection with simian immunodeficiency virus (SIV)
when the animals were depleted of CD4 T cells using an anti-
CD4 antibody (2, 19). Collectively, these studies suggest that
macrophage-tropic viruses evolve when CD4 T cells become
limiting. In the case of subject C018, this limitation may have
occurred in the genital tract tissue, in the absence of significant
mixing of this local virus with the blood. Our study identified
only one of five (20%) subjects who had compartmentalized
virus in the male genital tract as having macrophage-tropic
virus. We observed that two other subjects, C047 and C083,
had env genes that encoded proteins with an intermediate entry
phenotype, which could be evidence of the early steps of evo-
lution toward macrophage tropism. There is likely to be inter-
play between CD4 T cell migration into tissue, the local im-
mune response, and the level of local viral replication in the
tissue that determines if and when macrophage-tropic viruses
evolve, although this sampling of five subjects with compart-
mentalized virus is too small to define the individual contribu-
tions of these factors.
The correlation between the ability to efficiently infect Af-
finofile cells expressing low levels of CD4 and sensitivity to
inhibition of infectivity by sCD4 identifies these viruses in the
male genital tract of this subject as macrophage-tropic. This
shows that macrophage-tropic viruses can be found in other
tissues, outside the CNS. Additionally, these distinct evolution-
ary variants are present in the male genital tract and could be
transmitted (although this has not been observed [20, 21]) or
contribute to additional pathogenic mechanisms that would be
distinct for each tissue where such viruses evolve. At present,
we do not know if these viruses evolved in the genital tract to
become macrophage-tropic or if this evolution took place first
within the CNS and the virus migrated to another CD4 T
cell-poor environment.
FIG 2 Phylogenetic analysis of env sequences reveals compartmentaliza-
tion between the blood and seminal plasma. A neighbor-joining tree, cre-
ated using MEGA, of the sequences produced using SGA is shown. Filled
blue triangles represent env sequences from seminal plasma, and filled red
circles represent env sequences from blood plasma. The clustering of sem-
inal plasma env sequences into separate lineages and results of previously
described compartmentalization tests show distinct viral evolution within
the male genital tract. Cloned and tropism-analyzed env sequences are
marked with an asterisk (*) beside each label as indicated in the key.
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